Cell Growth & Differentiation, Vol 8, Issue 4 471-479, Copyright © 1997 by American Association of Cancer Research

ARTICLES

The 140-kilodalton antiangiogenic fragment of thrombospondin-1 binds to basic fibroblast growth factor

G Taraboletti, D Belotti, P Borsotti, V Vergani, M Rusnati, M Presta and R Giavazzi
Istituto di Ricerche Farmacologiche Mario Negri, Bergamo, Italy.

Thrombospondin-1 (TSP) inhibits the angiogenic activity of basic fibroblast growth factor (bFGF). Here we address the hypothesis of a direct interaction between TSP and bFGF. Gel permeation chromatography and cross-linking experiments demonstrated that bFGF binds to TSP in solution. bFGF also bound to immobilized TSP in a solid-phase assay. Binding was dose-dependent, with a Kd in the nanomolar range, and was inhibited by anti-TSP antibodies. The 140-kDa carboxyl-terminal fragment of TSP, but not the 25-kDa heparin-binding fragment, fully retained the bFGF binding capacity. Accordingly, binding was inhibited by monoclonal antibodies directed against this fragment. Heparin completely blocked bFGF binding to TSP and to the 140-kDa fragment. TSP and its 140-kDa fragment inhibited the binding of bFGF to endothelial cells at concentrations (> or = 100 nM) that inhibited endothelial cell proliferation but not motility. Low-affinity binding was inhibited more than high-affinity binding (up to 76 and 41% inhibition, respectively), and the inhibition was reversed by anti-TSP antibodies. Vitronectin and transforming growth factor beta, potentially associated with TSP, did not affect bFGF binding to endothelial cells. Although TSP did not affect the activation of the high-affinity receptors, it reduced the long-term internalization of bFGF. We conclude that TSP binds to bFGF through a domain within its 140-kDa fragment, a mechanism that might affect bFGF interaction with endothelial cells, activity, and association with the extracellular matrix.

This article has been cited by other articles:

				C. Bossard, L. V. d. Berghe, H. Laurell, C. Castano, M. Cerutti, A.-C. Prats, and H. Prats Antiangiogenic Properties of Fibstatin, an Extracellular FGF-2-Binding Polypeptide Cancer Res., October 15, 2004; 64(20): 7507 - 7512. [Abstract] [Full Text] [PDF]

				M. Rusnati, M. Camozzi, E. Moroni, B. Bottazzi, G. Peri, S. Indraccolo, A. Amadori, A. Mantovani, and M. Presta Selective recognition of fibroblast growth factor-2 by the long pentraxin PTX3 inhibits angiogenesis Blood, July 1, 2004; 104(1): 92 - 99. [Abstract] [Full Text] [PDF]

				A. W. Ashton, Y. Cheng, A. Helisch, and J. A. Ware Thromboxane A2 Receptor Agonists Antagonize the Proangiogenic Effects of Fibroblast Growth Factor-2: Role of Receptor Internalization, Thrombospondin-1, and {alpha}v{beta}3 Circ. Res., April 2, 2004; 94(6): 735 - 742. [Abstract] [Full Text] [PDF]

				B. Margosio, D. Marchetti, V. Vergani, R. Giavazzi, M. Rusnati, M. Presta, and G. Taraboletti Thrombospondin 1 as a scavenger for matrix-associated fibroblast growth factor 2 Blood, December 15, 2003; 102(13): 4399 - 4406. [Abstract] [Full Text] [PDF]

				A. Luque, D. R. Carpizo, and M. L. Iruela-Arispe ADAMTS1/METH1 Inhibits Endothelial Cell Proliferation by Direct Binding and Sequestration of VEGF165 J. Biol. Chem., June 20, 2003; 278(26): 23656 - 23665. [Abstract] [Full Text] [PDF]

				L. C. Armstrong, B. Bjorkblom, K. D. Hankenson, A. W. Siadak, C. E. Stiles, and P. Bornstein Thrombospondin 2 Inhibits Microvascular Endothelial Cell Proliferation by a Caspase-independent Mechanism Mol. Biol. Cell, June 1, 2002; 13(6): 1893 - 1905. [Abstract] [Full Text] [PDF]

				M. RUSNATI, G. TARABOLETTI, C. URBINATI, G. TULIPANO, R. GIULIANI, M. P. MOLINARI-TOSATTI, B. SENNINO, M. GIACCA, M. TYAGI, A. ALBINI, et al. Thrombospondin-1/HIV-1 Tat protein interaction: modulation of the biological activity of extracellular Tat FASEB J, October 1, 2000; 14(13): 1917 - 1930. [Abstract] [Full Text]

				T. Higuchi, H. Fujiwara, S. Yamada, K. Tatsumi, N. Kataoka, K. Itoh, M. Maeda, J. Fujita, and S. Fujii Co-expression of integrin-associated protein (IAP/CD47) and its ligand thrombospondin-1 on human granulosa and large luteal cells Mol. Hum. Reprod., October 1, 1999; 5(10): 920 - 926. [Abstract] [Full Text] [PDF]

				M. L. Iruela-Arispe, M. Lombardo, H. C. Krutzsch, J. Lawler, and D. D. Roberts Inhibition of Angiogenesis by Thrombospondin-1 Is Mediated by 2 Independent Regions Within the Type 1 Repeats Circulation, September 28, 1999; 100(13): 1423 - 1431. [Abstract] [Full Text] [PDF]

				K. Suzuma, H. Takagi, A. Otani, H. Oh, and Y. Honda Expression of Thrombospondin-1 in Ischemia-Induced Retinal Neovascularization Am. J. Pathol., February 1, 1999; 154(2): 343 - 354. [Abstract] [Full Text] [PDF]

				G. Fontanini, L. Boldrini, A. Calcinai, S. Chine, M. Lucchi, A. Mussi, C. A. Angeletti, F. Basolo, and G. Bevilacqua Thrombospondins I and II Messenger RNA Expression in Lung Carcinoma: Relationship with p53 Alterations, Angiogenic Growth Factors, and Vascular Density Clin. Cancer Res., January 1, 1999; 5(1): 155 - 161. [Abstract] [Full Text] [PDF]

				C. Perollet, Z. C. Han, C. Savona, J. P. Caen, and A. Bikfalvi Platelet Factor 4 Modulates Fibroblast Growth Factor 2 (FGF-2) Activity and Inhibits FGF-2 Dimerization Blood, May 1, 1998; 91(9): 3289 - 3299. [Abstract] [Full Text] [PDF]

				T. R. Kyriakides, Y.-H. Zhu, L. T. Smith, S. D. Bain, Z. Yang, M. T. Lin, K. G. Danielson, R. V. Iozzo, M. LaMarca, C. E. McKinney, et al. Mice That Lack Thrombospondin 2 Display Connective Tissue Abnormalities That Are Associated with Disordered Collagen Fibrillogenesis, an Increased Vascular Density, and a Bleeding Diathesis J. Cell Biol., January 26, 1998; 140(2): 419 - 430. [Abstract] [Full Text] [PDF]

				M. Rusnati, E. Tanghetti, P. Dell'Era, A. Gualandris, and M. Presta alpha vbeta 3 Integrin Mediates the Cell-adhesive Capacity and Biological Activity of Basic Fibroblast Growth Factor (FGF-2) in Cultured Endothelial Cells Mol. Biol. Cell, December 1, 1997; 8(12): 2449 - 2461. [Abstract] [Full Text]

				K. Russo, R. Ragone, A. M. Facchiano, M. C. Capogrossi, and A. Facchiano Platelet-derived Growth Factor-BB and Basic Fibroblast Growth Factor Directly Interact in Vitro with High Affinity J. Biol. Chem., January 4, 2002; 277(2): 1284 - 1291. [Abstract] [Full Text] [PDF]